Amanote Research
Register
Sign In
The Prognostic Significance of the Expression Change of EGFR During Neoadjuvant Chemoradiotherapy in Patients With Rectal Carcinoma
doi 10.5772/intechopen.73275
Full Text
Open PDF
Abstract
Available in
full text
Date
May 16, 2018
Authors
Igor Richter
Publisher
InTech
Related search
The Prognostic Significance of Tumor Epidermal Growth Factor Receptor (EGFR) Expression Change After Neoadjuvant Chemoradiation in Patients With Rectal Adenocarcinoma
Wspolczesna Onkologia
Oncology
Radiology
Nuclear Medicine
Imaging
Prognostic Significance of Clinical and Pathological Stages on Locally Advanced Rectal Carcinoma After Neoadjuvant Chemoradiotherapy
Radiation Oncology
Nuclear Medicine
Radiology
Imaging
Oncology
Prognostic Significance of Lung Radiation Dose in Patients With Esophageal Cancer Treated With Neoadjuvant Chemoradiotherapy
Radiation Oncology
Nuclear Medicine
Radiology
Imaging
Oncology
Neoadjuvant Chemoradiotherapy in Combined Treatment of Patients With Rectal Cancer
Grekov's Bulletin of Surgery
Role of Autophagy-Related Protein Expression in Patients With Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy
BMC Cancer
Cancer Research
Oncology
Genetics
MicroRNA Expression Profile Associated With Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients
Radiation Oncology
Nuclear Medicine
Radiology
Imaging
Oncology
Neoadjuvant Chemoradiotherapy in Rectal Cancer
Memo - Magazine of European Medical Oncology
Oncology
Hematology
Single Nucleotide Polymorphism TGFβ1 R25P Correlates With Acute Toxicity During Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Skeletal Muscle Loss Is an Independent Negative Prognostic Factor in Patients With Advanced Lower Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy
PLoS ONE
Multidisciplinary
